Login
$LRMR
$3.00 -$0.02 (0.66%) Live

Insider Transactions

What Larimar Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 7 15
Sells 0 0
Total trades 8 20

Shares traded

3 months 12 months
Acquired 190,810 5,539,788
Disposed 0 0
Net activity +190,810 +5,539,788

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Hamilton Thomas Edward Director Nov 12 Open-market buy · P +70,000 $2.67 +$187K 70,000
Ben-maimon Carole President and CEO Nov 11 Open-market buy · P +18,050 $2.77 +$50K 386,326
Thomas Frank E Director Nov 11 Open-market buy · P +8,000 $2.73 +$21.8K 15,000
Harlow John B. Jr. President and COO Nov 11 Open-market buy · P +17,800 $2.80 +$49.9K 67,800
Truitt Joseph Director Nov 11 Open-market buy · P +3,500 $2.80 +$9.79K 6,250
Celano Michael Chief Financial Officer Nov 11 Open-market buy · P +18,460 $2.71 +$50K 234,245
Shankar Gopi Chief Development Officer Nov 11 Open-market buy · P +5,000 $2.71 +$13.5K 81,443
Harlow John B. Jr. President and COO Sep 29 Grant / award · A +50,000 — — 50,000
Hamilton Thomas Edward Director Jul 06 Open-market buy · P +50,000 $3.34 +$167K 714,798
Flynn James E Director Feb 27 Open-market buy · P +2,000,000 $5.00 +$10M 6,207,982
Flynn James E Director Feb 27 Open-market buy · P +831,978 $5.00 +$4.16M 8,153,107
Flynn James E Director Feb 27 Open-market buy · P +1,084,012 $5.00 +$5.42M 10,622,957
Flynn James E Director Feb 27 Open-market buy · P +1,084,010 $5.00 +$5.42M 10,622,928
Sherman Jeffrey W Director Feb 27 Open-market buy · P +5,000 $5.00 +$25K 5,000
Hamilton Thomas Edward Director Feb 27 Open-market buy · P +100,000 $5.00 +$500K 664,798
Thomas Frank E Director Feb 27 Open-market buy · P +5,000 $5.00 +$25K 7,000
Ben-maimon Carole President and CEO Jan 26 Grant / award · A +100,100 — — 368,276
Clayton Russell Chief Medical Officer Jan 26 Grant / award · A +25,637 — — 71,443
Shankar Gopi Chief Development Officer Jan 26 Grant / award · A +25,637 — — 76,443
Celano Michael Chief Financial Officer Jan 26 Grant / award · A +37,604 — — 215,785

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support